Allen Capital Group LLC Grows Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Allen Capital Group LLC raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 607 shares of the medical equipment provider’s stock after purchasing an additional 48 shares during the quarter. Allen Capital Group LLC’s holdings in Intuitive Surgical were worth $317,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of ISRG. Strategic Blueprint LLC increased its holdings in Intuitive Surgical by 7.6% in the 4th quarter. Strategic Blueprint LLC now owns 3,504 shares of the medical equipment provider’s stock valued at $1,829,000 after acquiring an additional 248 shares during the last quarter. Hantz Financial Services Inc. raised its position in shares of Intuitive Surgical by 3.8% during the 4th quarter. Hantz Financial Services Inc. now owns 14,678 shares of the medical equipment provider’s stock valued at $7,661,000 after buying an additional 535 shares in the last quarter. Robeco Institutional Asset Management B.V. lifted its holdings in shares of Intuitive Surgical by 5.0% in the 4th quarter. Robeco Institutional Asset Management B.V. now owns 313,370 shares of the medical equipment provider’s stock valued at $163,567,000 after acquiring an additional 14,809 shares during the last quarter. Asset Dedication LLC increased its stake in Intuitive Surgical by 94.2% during the fourth quarter. Asset Dedication LLC now owns 534 shares of the medical equipment provider’s stock worth $279,000 after acquiring an additional 259 shares during the last quarter. Finally, R Squared Ltd purchased a new stake in Intuitive Surgical during the fourth quarter valued at approximately $251,000. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Trading Down 0.2 %

NASDAQ ISRG opened at $572.71 on Thursday. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The company has a fifty day simple moving average of $548.70 and a two-hundred day simple moving average of $507.04. The stock has a market cap of $203.99 billion, a P/E ratio of 92.08, a P/E/G ratio of 5.19 and a beta of 1.39.

Insider Buying and Selling

In related news, insider Jamie Samath sold 22,903 shares of the company’s stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $525.00, for a total value of $12,024,075.00. Following the completion of the transaction, the insider now owns 8,757 shares of the company’s stock, valued at approximately $4,597,425. This represents a 72.34 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at $6,955,015. The trade was a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 28,843 shares of company stock worth $15,357,560 in the last 90 days. Insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the topic of several recent research reports. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Robert W. Baird upped their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. Jefferies Financial Group raised their price target on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday. Citigroup increased their target price on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Finally, Wells Fargo & Company boosted their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.